
Genetically Modified Phages: Advancements in Human Health
Nexabiome is a UK biotech company that specialises in bacteriophage research with a particular focus on human and animal health applications.

Nexabiome is a UK biotech company that specialises in bacteriophage research with a particular focus on human and animal health applications.

Antibiotic resistance develops when bacteria become less sensitive to antibiotics, rendering them less effective or ineffective at killing bacteria and treating infections.

Bacteriophages are viruses that specifically target and destroy pathogenic bacteria, making them a promising research topic with significant implications for human health and the environment.

Personalised phage therapy is a therapeutic approach that involves using tailored bacteriophages to target and eliminate specific, harmful bacterial infections in a patient.

Bacteriophages, also known as phages or bacterial viruses, are a group of viruses that are capable of infecting bacteria.

Targeted drug delivery strategies are a vital part of the pipeline in converting a promising drug into a successful therapeutic strategy.